The latest market report published by Credence Research, Inc. “Metabolomics Market — Growth, Future Prospects, and Competitive Analysis, 2017–2025”, the global metabolomics market was valued at US$ 621.1 Mn in 2016 and is expected to reach US$ 2,428.1 Mn by 2025, expanding at a CAGR of 15.3% from 2017 to 2025.

Browse Full Report at https://www.credenceresearch.com/report/metabolomics-market

Market Insights

Metabolomics is the study of the chemical processes that involve small molecules known as metabolites, present within cells, tissues, biofluids or organisms. Metabolites are specific unique chemicals that are left behind in any cellular process, which can be studied for metabolite profiling. Such metabolites include amino acid, sugar, organic acids, and volatile metabolites, secondary metabolites include such as phenolic compounds, alkaloids, etc.; and pigments such as anthocyanins, carotenoids, etc. Metabolomics study helps in integrating technology and the biological pathway, and understand the interaction between cellular-level interactions with the environment which would produce metabolome. There is being increased in funding for research in academics, industry, and government. It is used in agricultural pharmaceutical and preventive healthcare industries etc. Due to its non-invasive nature of metabolomics and closely linked to phenotype makeup.

Metabolomics is the novel dynamic field that is continuously evolving. Along with proteomics, transcriptomics, and genomics, it is forming a robust integrative framework for further study of drug discovery and development. Though metabolomics is in the early budding phase, there is a conjecture that over a period of time it would be widely used in the biopharma industry for drug development. In the coming years, with the help of personalized metabolomics, we will be able to track the changes in the metabolome and further help in designing personalized drugs and improve the treatment strategies accordingly.

The global metabolomics market is segmented by product and service type as metabolomics instruments and metabolomics bioinformatics tools and services. Metabolomics instruments are sub-segmented into separation tools and detection tools. The separation tool includes high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis. Detection tools include mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis. Metabolomics is sub-segmented includes bioinformatics tools & databases and bioinformatics services. Metabolomics instruments occupy the largest market share of the global metabolomics market.

The global metabolomics market is segmented by application type biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others. Biomarker discovery dominates the global metabolomics market by application type. The global metabolomics market is segmented by indication type cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism and others. Cancer dominates the global metabolomics market by indication type.

As of the current market scenario, North America dominates the global metabolomics market due to a surge in research and development by government and private funding for metabolomics studies, easy accessibility in technological advancement in the equipment, rising demand for personalized medicine and toxicology testing. The Asia Pacific is the fastest growing metabolomics market due to the presence of a number of pharmaceutical and biotechnology companies and its initiatives in research and development, rise in disposable income and improving health care infrastructure.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58420

Market Competition Assessment:

Key players in the global metabolomics market are

Agilent Technologies, Inc., Acureomics AB, Amatsi Group, Bayer, Inc., Berg LLC, Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker Corporation, Chenomx, Inc, Danaher Corporation, Human Metabolome Technologies, Inc., HepatoChem, Inc., Human Metabolome Technologies, Inc., IROA Technologies, Leco Corporation, Metabolon, Inc., Max Planck Society, Metabolomic Discoveries GmbH, Metabolomx, Metabometrix Ltd., Metanomics GmbH, Phenomenome Discoveries, Inc., SCIEX, Shimadzu Corporation, SiDMAP, Stemina Biomarker Discovery, Inc, Thermo Fisher Scientific, Inc., Waters Corporation, Xceleron, Inc.

Key Market Movements:

With the advent of personalized medicine, diseases can be characterized at the molecular level and design and develop drug treatment according to individual. Metabolomics studies help in the characterization of disease phenotypes and further identify personal metabolic features that would help in predicting the response to the therapies. The rise in personalized medicine will boast the metabolomics market
There is being huge investments by government & pharma companies in the field of research and development of metabolomics. In biopharma R&D, the usage of metabolomics is showing a paradigm shift from preclinical space to transforming pharmacology and clinical development
Metabolomics is routinely used as a tool for biomarker discovery for informs decision making due to its potential advantage in terms of specificity and sensitivity

Browse Full Report at https://www.credenceresearch.com/report/metabolomics-market

Report Scope by Segments

By Product and Services Type

Metabolomics Instruments
Separation Tools
High-Performance Liquid Chromatography
Gas Chromatography
Ultra-Performance Liquid Chromatography
Capillary Electrophoresis
Detection Tools
Mass Spectrometry
Nuclear Magnetic Resonance Spectroscopy
Surface-Based Mass Analysis
Metabolomics Bioinformatics Tools and Services
Bioinformatics Tools & Databases
Bioinformatics Services

By Application Type

Biomarker Discovery
Drug Discovery
Functional Genomics
Personalized Medicine
Toxicology Testing
Nutrigenomics
Others

By Indication Type

Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism
Others

By Geography Segment

North America (the U.S., Rest of North America)
Europe (U.K., Germany, France, Rest of Europe)
Asia Pacific (China, Japan, India, Rest of Asia Pacific)
Rest of the World (the Middle East & Africa, Latin America)

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58420